(Q41014982)

25 September 2017

1 reference

title

Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates (English)

1 reference

25 September 2017

2

Bigner DD

1 reference

25 September 2017

Zalutsky MR

1

1 reference

25 September 2017

1 January 1996

1 reference

25 September 2017

1 reference

25 September 2017

35

1 reference

25 September 2017

373-379

1 reference

25 September 2017

3

1 reference

Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity

25 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101654

Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101654

Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101654

The preparation of astatine labelled proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101654

The preparation of astatine labelled proteins using an electrophilic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101654

Preparation of a biologically stable and immunogenically competent astatinated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101654

Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101654

10.3109/02841869609101654

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8679269